Propranolol induces a favourable shift of anti-tumor immunity in a murine spontaneous model of melanoma

In a previous study on a xenograft model of melanoma, we showed that the beta-adrenergic receptor antagonist propranolol inhibits melanoma development by modulating angiogenesis, proliferation and cell survival. Stress hormones can influence tumor development in different ways and norepinephrine was...

Descripción completa

Detalles Bibliográficos
Autores principales: Wrobel, Ludovic Jean, Bod, Lloyd, Lengagne, Renée, Kato, Masashi, Prévost-Blondel, Armelle, Gal, Frédérique-Anne Le
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Impact Journals LLC 2016
Materias:
Research Paper
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5363624/
https://www.ncbi.nlm.nih.gov/pubmed/27788481
http://dx.doi.org/10.18632/oncotarget.12833

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5363624/
https://www.ncbi.nlm.nih.gov/pubmed/27788481
http://dx.doi.org/10.18632/oncotarget.12833

Ejemplares similares